Comparative evaluation of seven oligonucleotide analogs as potential antisense agents

F. Morvan, Horea Porumb, Geneviève Degols, Isabelle Lefèbvre, Alain Pompon, Brian S. Sproat, Bernard Rayner, Claude Malvy, Bernard Lebleu, Jean‐Louis Imbach

Journal of Medicinal Chemistry · 1993 · 115 citations · 0 references

Abstract

12-Mer analogues, representative of seven different classes of structurally modified oligonucleotides and complementary to the same target, have been compared for their binding affinity for both single-stranded DNA and RNA, resistance to hydrolysis by nucleases in culture medium (RPMI 1640 + 10% inactivated fetal calf serum), and inhibition of HIV-1 replication in de novo infected MT4 T lymphocytes. The viral target was the splice acceptor site of the premessenger coding for the regulatory protein tat. The oligo(2'-O-alkyl)ribonucleotides (beta-2'O-allyl-RNA and beta-2'OMe-RNA) were shown to form the most stable hybrids with complementary RNA strands whereas the alpha-anomeric oligodeoxynucleoside phosphorothioate analogue displayed the highest stability in the culture medium. All the modified oligonucleotides examined in the present study exhibited a sequence-nonspecific inhibitory effect on HIV-1 replication, the phosphorothioate analogues being the most active ones (ED50 < 1 microM).